Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Improving emergency patient care

Date added:

Funding for emergency care research projects related to COVID-19 and lasting up to 1 year. Potential topics include diagnostics, safety, therapeutics, and crisis preparedness.

Amount
$5.000 - $25.000 (USD)
Agency or Funder
Society for Academic Emergency Medicine
Eligibility (if available)

Applicant must be a member of SAEM, hold a PhD or equivalent and a faculty university appointment with a department of emergency medicine

Date application deadline

Scientific collaboration between Muslim countries

Date added:

Grants available to enable collaborating groups in different IsDB countries to buy research equipment and strengthen facilities to enhance their partnership and productivity and to support the mobility of scientists between the participating insti

Amount
$50,000 (U.S.dollars) per research group
Agency or Funder
The World Academy of Sciences and the Islamic Development Bank
Eligibility (if available)

IsDB Member Countries, only PhD holders

Foreign participation? (where known)
No
Date application deadline

MRFF – 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity

Date added:

Proposals sought for a clinical trial that accelerates the implementation of treatments for severe acute respiratory distress in patients infected with COVID-19 in order to support the response to the COVID-19 outbreak in Australia.

Amount
$5M AUD
Agency or Funder
Australian National Health and Medical Research Council (NHMRC)
Eligibility (if available)

Applications will only be accepted from NHMRC approved Administering Institutions

Date application deadline

Research funding in Islamic countries

Date added:

Joint call from the UN World Academy of Sciences (TWAS) and the Islamic Development Bank for Research (IsDB) for epidemiology, diagnostic and treatments research in member states of the IsDB

Amount
$100,000 per grant
Agency or Funder
IsDB and TWAS
Eligibility (if available)

Each principal applicant must be a national of an IsDB country

Foreign participation? (where known)
No
Date application deadline

Emergency competitive revisions for research on repurposing existing therapeutics to address COVID-19.

Date added:

NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun.

Agency or Funder
National Center for Advancing Translational Sciences (NCATS)
Eligibility (if available)

Existing NCATS grantholders

Date application deadline

Translate promising preclinical findings into products for clinical applications

Date added:

Projects should include emerging viral diseases and respiratory health topics – and be relevant to the healthcare needs of military service members, veterans, military beneficiaries, and/or the American public.

Amount
$25M (U.S. dollars)
Agency or Funder
U.S. Department of Defense (DoD)
Eligibility (if available)

Government agencies, eligible non-DoD organization, DoD laboratory, DoD military treatment facility, and/or DoD activity embedded within a civilian medical centre

Foreign participation? (where known)
No
Date application deadline

Diagnostics, treatment and prevention for African countries

Date added:

Projects should focus on virology, epidemiology, health governance, transmission, information, mental health and vulnerable groups.

Amount
$4.75M USD
Agency or Funder
National Research Foundation South Africa
Eligibility (if available)

Researchers and science engagement practitioners from the following countries: Botswana, Burkina Faso, Côte d'Ivoire, Ethiopia, Ghana, Kenya, Malawi, Mozambique, Namibia, Rwanda, Senegal, Tanzania, Uganda, Zambia, Zimbabwe, and, in the context of the African Research Universities Alliance (ARUA), Nigeria and South Africa.

Foreign participation? (where known)
Yes
Date application deadline

Free transnational access to high-containment facilities

Date added:

Researchers investigating COVID-19 can get free access to high-containment research facilities, resources and services across Europe.

Amount
Access to high containment facilities
Agency or Funder
The European Research Infrastructure on Highly pathogenic Agents
Eligibility (if available)

Researchers or teams of researchers from anywhere

Foreign participation? (where known)
Yes
Date application deadline

Free transnational access to high containment facilities

Date added:

Researchers investigating COVID-19 can get free access to high containment research facilities, resources and services across Europe.

Amount
Access to high containment facilities
Agency or Funder
The European Research Infrastructure on Highly pathogenic Agents
Eligibility (if available)

Researchers or teams of researchers from anywhere

Foreign participation? (where known)
Yes
Date application deadline

Supplement for rapid implementation towards young researchers, CEPIDs and CPEs

Date added:

This funding opportunity will be a complementary financial support for researchers financed by grants from Tematico program, Centres of Research, Innovation and Diffusion (CEPID), Engineering Research Centres (CPEs) and Young researchers

Amount
R$10M
Agency or Funder
São Paulo Research Foundation (FAPESP)
Eligibility (if available)

Researchers financed in the areas of Tematico, Young Researcher, CEPID and CPE

Foreign participation? (where known)
No
Date application deadline

Preparing for future high-impact pandemics

Date added:

Research or innovation projects should enhance public preparedness for upcoming pandemics with medical, surveillance, sanitation, supply chain, education, and other technologies.

Agency or Funder
Eureka
Eligibility (if available)

At least two organisations from at least two of the following countries: Belgium, Canada, Estonia, Finland, France, the Netherlands, South Africa, Spain, Sweden, Turkey. Organisations from other Eureka countries can also participate

Foreign participation? (where known)
Yes
Date application deadline

The 2020 Call for Code Global Challenge for technology solutions to the pandemic

Date added:

Open call for developers, visionaries, and problem solvers to build open source technology solutions that address three main areas: crisis communication during an emergency, ways to improve remote learning, and how to inspire cooperative local com

Amount
$200,000 (U.S. dollars)
Agency or Funder
IBM
Eligibility (if available)

Developers, designers, and entrepreneurs over the age of 18 or the age of majority in their jurisdiction. Not eligible: Employees of IBM, David Clark Cause, and governmental agencies

Foreign participation? (where known)
Yes
Date application deadline

COVID-19 in vulnerable populations, its long-term effect, and the effectiveness of remdesivir

Date added:

Projects lasting up to 9 months should collect data on the clinical course and outcome of COVID-19 in vulnerable populations, investigate long-term consequences of COVID-19 in patients, or test the safety and effectiveness of remdesivir in treatin

Amount
Up to $250,000 USD
Agency or Funder
GILEAD
Foreign participation? (where known)
Yes
Date application deadline

Funding for research into mechanisms of immunoregulation

Date added:

Grants to identify key immune regulatory genes, signaling pathways, or mechanisms to contribute to the knowledge of the pathogenesis of infectious diseases.

Amount
$275,000 (for two- year project)
Agency or Funder
National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility (if available)

Higher Education Institutions, Nonprofits and For-Profit Organizations,State Governments ini the US.

Date application deadline

Aiding industrial competitiveness through R&D in COVID-19 technologies

Date added:

Projects must combine industrial and research partners and be focused on therapeutics and technologies.

Amount
Minimum of €4M, maximum of €50M (or potentially more)
Agency or Funder
Ministry of Higher Education and Research, and Bpifrance
Eligibility (if available)

Research teams must be based on a partnership between industrial and research actors

Date application deadline

Improving outcomes in people with cystic fibrosis

Date added:

The research should determine how susceptible cystic fibrosis (CF) cells are to COVID-19, identify and evaluate responses to the virus in people with CF, and understand how commonly prescribed medications used in CF may alter responses to the viru

Amount
Up to $125,000 USD per year
Agency or Funder
Cystic Fibrosis Foundation
Eligibility (if available)

Applicants must be independent investigators

Foreign participation? (where known)
Yes
Date application deadline

Initiating Phase I/II clinical trials on patients at risk or already infected

Date added:

Projects should leverage clinical trials expertise to rapidly intiate clinical trials for prevention and/or treatment for COVID-19

Amount
Not limited
Agency or Funder
National Heart, Lung, and Blood Institute
Eligibility (if available)

Must already possess an NHLBI Phase I-III clinical trial award

Foreign participation? (where known)
No
Date application deadline

Broad opportunities for research funding related to COVID-19

Date added:

BARDA is looking to help the development of products to diagnose, prevent or treat novel coronavirus infections. (BARDA will only accept submissions related to the SARS-CoV-2 virus or the COVID-19 disease until further notice.)

Amount
Unlimited
Agency or Funder
Biomedical Advanced Research and Development Authority (BARDA)
Eligibility (if available)

Single entities or teams from private sector organizations, Government laboratories, and academic institutions.

Date application deadline